Global Dermatology Diagnostic Devices Market, By Diagnostic Device (Imaging Device, Dermatoscope, Microscope), Treatment Device (Electrosurgical, Cryotherapy, Laser), Type (Dermatoscopes, Imaging Equipment, Microscopes and Trichoscopes, Biopsy Devices, Others), Application (Skin Cancer, Others), End-User (Hospitals, Clinics, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Growing consciousness among the individuals to look good in public, thereby, resulting in the feeling of confidence and courage has carved the way for the growth of innovations in the dermatology department. Growing number of product innovations by the major manufacturers has resulted in the availability of high grade and high quality dermatology diagnostic devices all around the globe.
- Data Bridge Market Research analyses that the dermatology diagnostic devices market is expected to undergo a CAGR of 13.10% during the forecast period. This indicates that the market value, which was USD 13.10 billion in 2021, would rocket up to USD 33.87 billion by 2029. “Imaging Device” dominates the product segment of the dermatology diagnostic devices market owing to the rising number of hospitals and clinics especially in the developing economies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
From the name itself, it is clear that dermatology diagnostic devices are the medical devices that are used to study the skin and diagnose it for any diseases including suggesting treatment alternatives. The dermatology diagnostic devices are efficient and effective in diagnosing skin diseases such as acne, pigmentation, skin cancer and psoriasis.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Diagnostic Device (Imaging Device, Dermatoscope, Microscope), Treatment Device (Electrosurgical, Cryotherapy, Laser), Type (Dermatoscopes, Imaging Equipment, Microscopes and Trichoscopes, Biopsy Devices, Others), Application (Skin Cancer, Others), End-User (Hospitals, Clinics, Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Agfa-Gevaert Group (Belgium), Carl Zeiss AG (Germany), MELA Sciences, Inc. (US), Hologic, Inc. (US), Illumina, Inc. (US), Spindletop Capital (US), Heine Optotechnik (Germany), GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), Leica Microsystems (Germany), Bruker (US), Solta Medical (US), CANDELA CORPORATION (US), Ambicare Health (UK), Siemens Healthcare Private Limited (Germany), Welch Allyn (US), CANON MEDICAL SYSTEMS CORPORATION (Japan), Galderma laboratories (US), Michelson Diagnostics Inc. (UK) and Canfield Scientific, Inc. (US)
Dermatology Diagnostic Devices Market Dynamics
The rise in the prevalence of cancer
Surging prevalence of skin cancer coupled with other dermatological diseases all around the globe is one of the major factors responsible for fostering growth in the market value. According to Skin Cancer Foundation, more than 10,130 people die of melanoma every year in the United States.
Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for tissue regeneration procedures is also bolstering the market growth rate.
Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Moreover, stringent regulations imposed by the government on industries pertaining to the air pollution will also work in the favour of the market.
Additionally, surge in the personal disposable income level, introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices and presence of several pollutants such as polycyclic aromatic hydrocarbons, oxides and ultraviolet radiation causing damage to the skin, positively affect the market growth rate.
Furthermore, upsurge in the public-private funding for target research activities, increasing levels of air pollution, growing number of aesthetic procedures, increasing awareness regarding melanoma among patients and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, availability of devices for performing imaging techniques in the developing regions and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and high associated with the skin disorder treatments and diagnostic procedures are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, complications pertaining to the skin surgical procedures, competitive pricing by low-cost manufacturers, availability of low-cost substitutes and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This dermatology diagnostic devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dermatology diagnostic devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Dermatology Diagnostic Devices Market
COVID-19 has significantly and negatively impacted the market. The funding for research and development activities was significantly reduced and cut down. Non-essential business witnessed disruption in every department. Supply chain disruptions demoted the market demand and supply. Shifting focus towards the essential healthcare procedures during this phase put a halt on unnecessary operations. There was a huge postponement on the non-essential medical procedures. People grew more towards to online and home care treatments. All of this proved to be a bane for the market during pandemic.
- In Jul 2020, Lancer Skincare announced the launch of its very first skincare exfoliating device, the Pro Polish Microdermabrasion Device. Pro Polish enhances the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device.
- In Jan 2020, 3Derm Systems, Inc. (3Derm) announced that it was granted two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.
Global Dermatology Diagnostic Devices Market Scope
The dermatology diagnostic devices market is segmented on the basis of diagnostic device, treatment device, type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Imaging Device
On the basis of diagnostic device, the dermatology diagnostic devices market is segmented into imaging device, dermatoscope and microscope.
On the basis of treatment device, the dermatology diagnostic devices market is segmented into electrosurgical, cryotherapy and laser.
- Imaging Equipment
- Microscopes and Trichoscopes
- Biopsy Devices
On the basis of type, the dermatology diagnostic devices market is segmented into dermatoscopes, imaging equipment, microscopes and trichoscopes, biopsy devices and others.
- Skin Cancer
On the basis of application, the dermatology diagnostic devices market is segmented into skin cancer and others.
On the basis of end-user, the dermatology diagnostic devices market is segmented into hospitals, clinics and others.
Dermatology Diagnostic Devices Market Regional Analysis/Insights
The dermatology diagnostic devices market is analysed and market size insights and trends are provided by country, diagnostic device, treatment device, type, application and end-user as referenced above.
The countries covered in the dermatology diagnostic devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the dermatology diagnostic devices market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, growing number of processes pertaining to drug development, increasing incidences of skin disorders such as psoriasis and melanoma and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, rising prevalence of skin cancer and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The dermatology diagnostic devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cancer biomarkers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the dermatology diagnostic devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Dermatology Diagnostic Devices Market Share Analysis
The dermatology diagnostic devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dermatology diagnostic devices market.
Some of the major players operating in the dermatology diagnostic devices market are Agfa-Gevaert Group (Belgium), Carl Zeiss AG (Germany), MELA Sciences, Inc. (US), Hologic, Inc. (US), Illumina, Inc. (US), Spindletop Capital (US), Heine Optotechnik (Germany), GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), Leica Microsystems (Germany), Bruker (US), Solta Medical (US), CANDELA CORPORATION (US), Ambicare Health (UK), Siemens Healthcare Private Limited (Germany), Welch Allyn (US), CANON MEDICAL SYSTEMS CORPORATION (Japan), Galderma laboratories (US), Michelson Diagnostics Inc. (UK) and Canfield Scientific, Inc. (US) among others.
Research Methodology : Global Dermatology Diagnostic Devices Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available : Global Dermatology Diagnostic Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.